Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CHK-336 in Healthy Volunteers
Clinical trial NCT05367661 · TERMINATED
Trial details
- NCT number
- NCT05367661
- Sponsor
- Chinook Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-08
- Primary completion
- 2023-04-19
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.